期刊文献+

Molecular aspects of carcinogenesis in pancreatic cancer 被引量:4

Molecular aspects of carcinogenesis in pancreatic cancer
下载PDF
导出
摘要 BACKGROUND:Pancreatic cancer(PCa)is one of the most aggressive human solid tumors,with rapid growth and metastatic spread as well as resistance to chemotherapeutic drugs,leading rapidly to virtually incurable disease.Over the last 20 years,however,significant advances have been made in our understanding of the molecular biology of PCa,with a focus on the cytogenetic abnormalities in PCa cell growth and differentiation. DATA SOURCES:A MEDLINE search and manual cross- referencing were utilized to identify published data for PCa molecular biology studies between 1986 and 2008, with emphasis on genetic alterations and developmental oncology. RESULTS:Activation of oncogenes,deregulation of tumor suppressor and genome maintenance genes,upregulation of growth factors/growth factor receptor signaling cascade systems,and alterations in cytokine expression,have been reported to play important roles in the process of pancreatic carcinogenesis.Alterations in the K-ras proto- oncogene and the p16INK4a,p53,FHIT,and DPC4 tumor suppressor genes occur in a high percentage of tumors. Furthermore,a variety of growth factors are expressed at increased levels.In addition,PCa often exhibits alterations in growth inhibitory pathways and evades apoptosis through p53 mutations and aberrant expression of apoptosis-regulating genes,such as members of the Bcl family.Additional pathways in the development of an aggressive phenotype,local infiltration and metastasis are still under ongoing genetic research.The present paper reviews recent studies on the pathogenesis of PCa,and includes a brief reference to alterations reported for other types of pancreatic tumor. CONCLUSIONS:Advances in molecular genetics and biology have improved our perception of the pathogenesis of PCa.However,further studies are needed to better understand the fundamental changes that occur in PCa,thus leading to better diagnostic and therapeutic management. BACKGROUND:Pancreatic cancer(PCa)is one of the most aggressive human solid tumors,with rapid growth and metastatic spread as well as resistance to chemotherapeutic drugs,leading rapidly to virtually incurable disease.Over the last 20 years,however,significant advances have been made in our understanding of the molecular biology of PCa,with a focus on the cytogenetic abnormalities in PCa cell growth and differentiation. DATA SOURCES:A MEDLINE search and manual cross- referencing were utilized to identify published data for PCa molecular biology studies between 1986 and 2008, with emphasis on genetic alterations and developmental oncology. RESULTS:Activation of oncogenes,deregulation of tumor suppressor and genome maintenance genes,upregulation of growth factors/growth factor receptor signaling cascade systems,and alterations in cytokine expression,have been reported to play important roles in the process of pancreatic carcinogenesis.Alterations in the K-ras proto- oncogene and the p16INK4a,p53,FHIT,and DPC4 tumor suppressor genes occur in a high percentage of tumors. Furthermore,a variety of growth factors are expressed at increased levels.In addition,PCa often exhibits alterations in growth inhibitory pathways and evades apoptosis through p53 mutations and aberrant expression of apoptosis-regulating genes,such as members of the Bcl family.Additional pathways in the development of an aggressive phenotype,local infiltration and metastasis are still under ongoing genetic research.The present paper reviews recent studies on the pathogenesis of PCa,and includes a brief reference to alterations reported for other types of pancreatic tumor. CONCLUSIONS:Advances in molecular genetics and biology have improved our perception of the pathogenesis of PCa.However,further studies are needed to better understand the fundamental changes that occur in PCa,thus leading to better diagnostic and therapeutic management.
出处 《Hepatobiliary & Pancreatic Diseases International》 SCIE CAS 2008年第4期345-356,共12页 国际肝胆胰疾病杂志(英文版)
关键词 CARCINOGENESIS gene regulation cell growth signaling growth factors growth factor receptors APOPTOSIS CYTOKINES carcinogenesis gene regulation cell growth signaling growth factors growth factor receptors apoptosis cytokines
  • 相关文献

参考文献190

  • 1MingDong Jian-PingZhou HaoZhang Ke-JanGuo Yu-Lin-Tian Yu-TingDong.Clinicopathological significance of Bcl-2 and Bax protein expression in human pancreatic cancer[J].World Journal of Gastroenterology,2005,11(18):2744-2747. 被引量:7
  • 2Guido M. Sclabas,Shuichi Fujioka,Christian Schmidt,Douglas B. Evans,Paul J. Chiao.NF-κB in pancreatic cancer[J]. International Journal of Gastrointestinal Cancer . 2003 (1)
  • 3Hubert G. Hotz M.D.,O. Joe Hines M.D.,Birgit Hotz,Thomas Foitzik M.D.,Heinz J. Buhr M.D.,Howard A. Reber M.D..Evaluation of vascular endothelial growth factor blockade and matrix metalloproteinase inhibition as a combination therapy for experimental human pancreatic cancer[J]. Journal of Gastrointestinal Surgery . 2003 (2)
  • 4Richard J. Bold M.D.,Kenneth R. Hess Ph.D.,A. Scott Pearson M.D.,Ana M. Grau M.D.,Frank A. Sinicrope M.D.,Mary Jennings R.N.,David J. McConkey Ph.D.,Corazon D. Bucana Ph.D.,Karen R. Chary M.D.,Pamela A. Hallin Pharm.D.,Paul J. Chiao Ph.D.,James L. Abbruzzese M.D.,Douglas B. Evans M.D..Prognostic factors in resectable pancreatic cancer: p53 and Bcl-2[J]. Journal of Gastrointestinal Surgery . 1999 (3)
  • 5Richard J. Bold MD,Joya Chandra BS,David J. McConkey PhD.Gemcitabine-Induced Programmed Cell Death (Apoptosis) of Human Pancreatic Carcinoma Is Determined by Bcl-2 Content[J]. Annals of Surgical Oncology . 1999 (3)
  • 6Sanaa T. Dergham,Michael C. Dugan,Fazlul H. Sarkar,Vainutis K. Vaitkevicius.Molecular alterations associated with improved survival in pancreatic cancer patients treated with radiation or chemotherapy[J]. Journal of Hepato - Biliary - Pancreatic Surgery . 1998 (3)
  • 7E. M. Castellà,A. Ariza,I. Ojanguren,J. L. Mate,X. Roca,A. Fernández-Vasalo,J. J. Navas-Palacios.Differential expression of CD44v6 in adenocarcinoma of the pancreas: an immunohistochemical study[J]. Virchows Archiv . 1996 (4-5)
  • 8H. Friess,P. Berberat,M. Schilling,J. Kunz,M. W. Büchler,M. Korc.Pancreatic cancer: the potential clinical relevance of alterations in growth factors and their receptors[J]. Journal of Molecular Medicine . 1996 (1)
  • 9Carlos Caldas,Scott E. Kern.K-ras mutation and pancreatic adenocarcinoma[J]. International Journal of Pancreatology . 1995 (1)
  • 10F. Sessa,E. Solcia,C. Capella,M. Bonato,A. Scarpa,G. Zamboni,N. S. Pellegata,G. N. Ranzani,F. Rickaert,G. Kl?ppel.Intraductal papillary-mucinous tumours represent a distinct group of pancreatic neoplasms: an investigation of tumour cell differentiation and K-ras, p53 and c-erbB-2 abnormalities in 26 patients[J]. Virchows Archiv . 1994 (4)

二级参考文献1

共引文献17

同被引文献5

引证文献4

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部